Zapata Quantum announced that CEO Sumit Kapur will present live at the Global Technology Virtual Investor Conference on July 9, highlighting the company's collaboration with NVIDIA to accelerate quantum algorithm development and its quantum-enabled cancer drug discovery research recognized as a Top 10 paper by Nature Biotechnology. The company recently completed a $15 million fundraising round and expanded its leadership team with quantum software experts. This presentation offers investors a chance to learn about Zapata's advances in quantum computing applications in biotech and other fields, with live Q&A and follow-up meetings available.
GrowGeneration Corp., a leading supplier for controlled environment agriculture, has joined the U.S. Cannabis Roundtable (USCR) to help shape federal cannabis regulations. Represented by CEO Darren Lampert, GrowGeneration aims to leverage its agricul...
Keith Ablow, a New York Times bestselling author and psychiatrist, has released a new novel titled 'A Matter of Life and Death: The Importance of Being Kane' on July 30, 2026. The book explores themes of radical reinvention, identity, and authenticit...
YieldMax declared monthly distributions for its Target 12™ ETFs: BIGY (Big 50 Option Income), RNTY (Real Estate Option Income), and SOXY (Semiconductor Option Income). Each ETF targets a 12% annual income level, with distributions scheduled for July ...
YieldMax ETFs announced their weekly distributions for Group 1 option income ETFs, with payments scheduled for July 9, 2026. The distributions vary by ETF, with rates ranging from about 24.75% to over 60% annualized, reflecting income generated prima...
The global Transthyretin Amyloidosis Treatment Market, valued at $8.95 billion in 2025, is projected to reach $35.10 billion by 2035 with a CAGR of 14.64%. Growth is fueled by advances in gene-silencing RNAi therapies like patisiran and vutrisiran, i...
